Macrogen Inc
038290
Company Profile
Business description
Macrogen Inc provides DNA sequencing and genome research services. Its business divisions are sequencing, oligo, microarray, mouse, and bioinformatics. The firm's products and services include DNA, Chip and Genetic Medicine products and Database construction, Genome Research and Bioinformatics analysis system consulting services.
Contact
Cherry Blossom-ro, 10th Floor
Gasan-dong, World Meridien 1st
Seoul
KORT: +82 221137000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
529
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
With the monetization of GenAI, here’s what we think of Alphabet’s stock
stocks
Going into earnings, Is Meta stock a buy, a sell, or fairly valued?
With a focus on leveraging its AI investments, here’s what we think of Meta stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,941.50 | 15.30 | 0.17% |
| CAC 40 | 7,750.71 | 47.51 | -0.61% |
| DAX 40 | 24,050.32 | 257.48 | -1.06% |
| Dow JONES (US) | 44,454.27 | 131.20 | 0.30% |
| FTSE 100 | 9,019.99 | 7.00 | 0.08% |
| HKSE | 25,130.03 | 135.89 | 0.54% |
| NASDAQ | 20,883.13 | 91.04 | -0.43% |
| Nikkei 225 | 39,774.92 | 44.19 | -0.11% |
| NZX 50 Index | 12,833.74 | 127.77 | -0.99% |
| S&P 500 | 6,304.28 | 1.32 | -0.02% |
| S&P/ASX 200 | 8,677.20 | 9.00 | 0.10% |
| SSE Composite Index | 3,581.86 | 22.07 | 0.62% |